Vyndaqel

Manufacturer
Pfizer Labs Division of Pfizer Inc. | DELMAR CHEMICALS INC | Catalent Pharma Solutions, LLC | AndersonBrecon Inc. | Catalent Micron Technologies, Inc.
Effective date
2016-01-13
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
3
Source
legacy-cache
Hydrated at
2026-08-02 01:29:27

Label at a glance#

ProductVyndaqel
Active ingredientTAFAMIDIS MEGLUMINE
Label structure2 sections

Label contents#

Full prescribing information#

PRINCIPAL DISPLAY PANEL - 20 mg Blister Pack Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Vyndaqel® 20 mg

tafamidis meglumina

Pfizer

PRINCIPAL DISPLAY PANEL - 20 mg Blister Pack Carton
PRINCIPAL DISPLAY PANEL - 20 mg Blister Pack Carton

PRINCIPAL DISPLAY PANEL - 20 mg Blister Pack

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Vyndaqel® 20 mg

tafamidis meglumina
Pfizer

PRINCIPAL DISPLAY PANEL - 20 mg Blister Pack
PRINCIPAL DISPLAY PANEL - 20 mg Blister Pack

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 12 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
0069-87290069-8729-55

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
bb04e5f6-211e-4964-8d26-b0db54d4f578417238d2-98dd-47b4-95c5-5c06dc3702dc2026-05-13Exact identifier
spl set id: 417238d2-98dd-47b4-95c5-5c06dc3702dc

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.